Cintas Corp Q1 2024 Earnings Call Summary

The following is excerpted from the question-and-answer section of the transcript.

Question: Joshua K. Chan - UBS Investment Bank, Research Division - Analyst : I guess could I ask about inflation and what you're seeing across your different cost buckets, labor, energy, material? And how you expect that to kind of transpire over the coming quarters as well?

Question: Joshua K. Chan - UBS Investment Bank, Research Division - Analyst : And I guess for my follow-up, could you talk about what your CapEx expectations are this year and kind of the types of projects that you're investing in?

Question: Samuel Kusswurm - William Blair & Company L.L.C., Research Division - Analyst : This is Sam Kusswurm on for Tim. I guess I want to start with another health care question here. But as it relates to your health care clients, you've talked a lot about the opportunity here, especially as more no programmers convert. But I guess I'd like to know for those health care operators who already use a service partner, what do you think your penetration rate is? And how might that compare to some of your other customer verticals?

Question: Samuel Kusswurm - William Blair & Company L.L.C., Research Division - Analyst : Got you. Appreciate it. Maybe just another quick one on the margins. I see SG&A as a percentage of sales picked up again in the quarter compared to last year. I guess I'm wondering if there was any variable costs like your insurance expenses? Or if it was mainly some of the selling and branding investments you've talked about previously? Maybe you could just help break that out for us a little more. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. SEPTEMBER 26, 2023 / 2:00PM, CTAS.OQ - Q1 2024 Cintas Corp Earnings Call